Zimmer Biomet Holdings(ZBH-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Zimmer Biomet Holdings

345 EAST MAIN STREET
WARSAW IN 46580 USA
P: 574-373-3333
http://www.zimmerbiomet.com

Profile

Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

Key Executives

NameTitle
Paul StellatoCFO/Chief Accounting Officer/Controller/Vice President

More from The Globe

Thursday’s Insider Report: Multiple executives sell shares in this stock that’s doubled in 2026
Technicians put the final touches on the second of three Radarsat Constellation Mission satellites at the MDA facility Thursday, June 21, 2018 in Montreal.
Dye & Durham dumps CEO, Tyler Proud now leads company through board committee
The Bay Street financial district of Toronto is shown on Sunday Sept. 8, 2024. THE CANADIAN PRESS/Doug Ives
number cruncher
Searching for European momentum stocks in a frothy market
For Number Cruncher column in Globe Investor/ROB only.
Bullish potential on Intact Financial Corp.
Monica Rizk
top links
Barlow’s Research Roundup: These stocks are the big winners from Canada’s new nuclear energy plan
Future headquarters of Ontario Power Generation, Oshawa, March 2025.
trade secrets
Where will tech stocks go from here?
Happy man investor. Crypto currency up trend. Growth chart concept. Trade Chart. Cryptocurrency mining, bitcoin exchange, blockchain and marketing technology, internet money flat vector illustration.
Six bargain stock picks from hedge fund managers
forex candlestick charts monitored
Gildan stock is down, and looking good
Signage is seen at Gildan Activewear Inc.'s annual meeting in Montreal, Tuesday, May 28, 2024. THE CANADIAN PRESS/Christinne Muschi

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.